See more : nDivision Inc. (NDVN) Income Statement Analysis – Financial Results
Complete financial analysis of Brilliant Acquisition Corporation (BRLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brilliant Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Apyx Medical Corporation (APYX) Income Statement Analysis – Financial Results
- KATITAS CO., Ltd. (8919.T) Income Statement Analysis – Financial Results
- Jihua Group Corporation Limited (601718.SS) Income Statement Analysis – Financial Results
- Entero Healthcare Solutions Limited (ENTERO.NS) Income Statement Analysis – Financial Results
- H. Lundbeck A/S (HLBBF) Income Statement Analysis – Financial Results
Brilliant Acquisition Corporation (BRLI)
Industry: Shell Companies
Sector: Financial Services
About Brilliant Acquisition Corporation
Brilliant Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2019 and is based in Shanghai, China.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.20M | 670.92K | 148.01K | 0.00 |
| Gross Profit | -1.20M | -670.92K | -148.01K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.20K | 670.92 | 148.01 | 35.42 |
| Other Expenses | 1.20M | 670.92K | 148.01K | 0.00 |
| Operating Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
| Cost & Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
| Interest Income | 64.95K | 4.63K | 3.06K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -169.84K | -67.16K | 172.79K | 171.86K |
| EBITDA | -1.37M | -670.92K | 24.78K | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.20M | -670.92K | -148.01K | -35.42 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 234.79K | 71.79K | -169.73K | 0.00 |
| Income Before Tax | -967.61K | -599.13K | -317.74K | -35.42 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -234.79K | -4.63K | -3.06K | 0.00 |
| Net Income | -732.83K | -594.49K | -314.68K | -35.42 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.10 | -0.09 | 0.00 |
| EPS Diluted | -0.16 | -0.10 | -0.09 | 0.00 |
| Weighted Avg Shares Out | 4.64M | 6.11M | 3.70M | 0.00 |
| Weighted Avg Shares Out (Dil) | 4.64M | 6.11M | 3.70M | 0.00 |
Phillip Md Et Al Frost Buys 400,000 Shares of Opko Health Inc. (NASDAQ:OPK) Stock
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost bought 400,000 shares of Opko Health stock in a transaction on Tuesday, April 7th. The stock was acquired at an average cost of $1.28 per share, for a total transaction...
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Buys 50,000 Shares of Stock
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost bought 50,000 shares of the company’s stock in a transaction on Friday, April 3rd. The stock was bought at an average cost of $1.23 per share, for a total transaction...
Opko Health (NASDAQ:OPK) Trading 16.4% Higher on Insider Buying Activity
Opko Health Inc. (NASDAQ:OPK)’s share price traded up 16.4% during mid-day trading on Monday after an insider bought additional shares in the company. The company traded as high as $1.35 and last traded at $1.35, 14,028,878 shares traded hands during...
Connor Clark & Lunn Investment Management Ltd. Has $944,000 Stake in Opko Health Inc. (NASDAQ:OPK)
Connor Clark & Lunn Investment Management Ltd. lowered its stake in Opko Health Inc. (NASDAQ:OPK) by 16.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 642,008 shares of the biotechnology company’s stock after selling 122,327 shares during...
Opko Health Inc. (NASDAQ:OPK) CEO Acquires $752,952.33 in Stock
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost purchased 643,549 shares of the firm’s stock in a transaction on Wednesday, April 1st. The stock was bought at an average price of $1.17 per share, for a total transaction...
Raymond James Financial Services Advisors Inc. Increases Stock Holdings in Opko Health Inc. (NASDAQ:OPK)
Raymond James Financial Services Advisors Inc. grew its position in Opko Health Inc. (NASDAQ:OPK) by 24.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor...
Opko Health (NASDAQ:OPK) Shares Gap Up on Insider Buying Activity
Opko Health Inc. (NASDAQ:OPK)’s share price gapped up before the market opened on Friday following insider buying activity. The stock had previously closed at $1.10, but opened at $1.15. Opko Health shares last traded at $1.16, with a volume of...
Credit Suisse AG Increases Stock Position in Opko Health Inc. (NASDAQ:OPK)
Credit Suisse AG increased its position in Opko Health Inc. (NASDAQ:OPK) by 18.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 607,686 shares of the biotechnology company’s stock after...
Mercer County coronavirus testing site swabs over 250 people in 3 days
The appointment-only site will test people showing symptoms for coronavirus who have a prescription.
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 161,968 Shares
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost acquired 161,968 shares of the firm’s stock in a transaction that occurred on Monday, March 30th. The shares were bought at an average price of $1.35 per share, for a...
Source: https://incomestatements.info
Category: Stock Reports